Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA
- 6 July 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 307 (1) , 45-48
- https://doi.org/10.1016/s0304-3940(01)01923-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Different regulation of RGS2 mRNA by haloperidol and clozapineNeuroReport, 2001
- Regulators of G Protein SignalingJournal of Neurochemistry, 2000
- Atypical antipsychotics: an inspiring but confusing conceptPsychopharmacology, 2000
- Emerging roles for RGS proteins in cell signallingPublished by Elsevier ,1999
- RGS mRNA Expression in Rat StriatumJournal of Neurochemistry, 1999
- Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal PlasticityJournal of Neuroscience, 1998
- Regulators of G Protein Signaling: Rapid Changes in mRNA Abundance in Response to AmphetamineJournal of Neurochemistry, 1998
- RGS4 and GAIP are GTPase-activating proteins for G qα and block activation of phospholipase Cβ by γ-thio-GTP-G qαProceedings of the National Academy of Sciences, 1997
- Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor bindingPsychopharmacology, 1996
- Differential expression of inducible transcription factors in basal ganglia neuronsMolecular Brain Research, 1995